News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
Tandem Diabetes Care Announces Pricing Of Underwritten Public Offering Of Common Stock 2/27/2015
Tianyin Pharmaceutical Co, Inc. Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 2/27/2015
Organovo Holdings, Inc. To Provide Corporate Update And Investor Presentation In A Live, Interactive Webcast On March 5th 2/27/2015
Transgenomic, Inc. (TBIO) Announces Pricing Of Public Offering Of Common Stock 2/27/2015
Tekla Healthcare Opportunities Fund Pays Distribution 2/27/2015
Teva Pharmaceutical Industries (TEVA) Announces Early Results Of Debt Tender Offer, Pricing, Election Of Early Settlement And Increase In Maximum Amount And Priority 2 Notes Tender Cap 2/27/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 2/27/2015
Presentation Of The Result Of Medivir AB (MVRBF)’s Voluntary Redemption Programme 2/27/2015
ESSA Pharma And Bloom Burton Announce Additional Release Of Shares From Voluntary Lock-Up Agreement 2/27/2015
Cortendo AB: Cortendo Announces Notice Of Extraordinary General Meeting 2/27/2015
Change In The Total Number Of Shares And Votes In Recipharm AB 2/27/2015
Change In Number Of Shares And Votes In Aerocrine 2/27/2015
Alnylam (ALNY)’s “Incredibly Deep” Pipeline Continues to Impress As Commercial Stage Looms, Says Analyst 2/27/2015
Market Analysis: Pharmacyclics (PCYC) Sale Good Idea if Buyer Understands Imbruvica Potential, Says Analyst 2/26/2015
Nine Ways to Avoid Investing in Biotech Duds 2/26/2015
TherapeuticsMD, Inc.  (TXMD) Has "Multiple Catalysts" in 2015/16 As Products Develop, Says Cowen and Company 2/26/2015
AMAG Pharmaceuticals, Inc. (AMAG) Prices Public Offering Of $175 Million Of Common Stock 2/26/2015
Lion Biotechnologies, Inc. Announces Public Offering Of Common Stock 2/26/2015
CollabRx, Inc.Announces Proposed Public Offering Of Common Stock 2/26/2015
Lion Biotechnologies, Inc. Prices Public Offering Of Common Stock 2/26/2015
PDL BioPharma, Inc. (PDLI) To Hold Annual Meeting Of Stockholders On May 28, 2015 2/26/2015
CollabRx, Inc. Announces Pricing Of Public Offering Of Approximately $3,000,000 Of Common Stock 2/26/2015
Relypsa, Inc. (RLYP) Announces Pricing Of Public Offering Of Common Stock 2/26/2015
Cardio3 BioSciences To Raise Capital Via A Private Placement Of New Shares 2/26/2015
Opexa Therapeutics (OPXA) Announces Record Date And Subscription Price For Rights Offering 2/26/2015
Salix (SLXP) Provides Notice Of Anticipated Make-Whole Fundamental Change To Holders Of Its 1.5% Convertible Senior Notes Due 2019 2/26/2015
Ocata Therapeutics Approved For Listing On NASDAQ 2/26/2015
Chairman Of The Board Of Institute Of Organic Synthesis Ivars Kalvinsh Purchased Shares Of The International Holding-Company "Rigvir" 2/26/2015
Celldex (CLDX) Prices Public Offering Of Common Stock 2/26/2015
Tandem Diabetes Care Announces Proposed Underwritten Public Offering Of Common Stock 2/25/2015
ContraVir Pharmaceuticals Announces Uplisting to The NASDAQ Capital Market 2/25/2015
Xencor Prices Public Offering Of Common Stock 2/25/2015
Curis, Inc. (CRIS) Prices Public Offering Of Common Stock 2/25/2015
Check-Cap Announces Closing Of Initial Public Offering And Simultaneous Private Placement 2/25/2015
Relypsa, Inc. (RLYP) Announces Proposed Public Offering Of Common Stock 2/25/2015
Curis, Inc. (CRIS) Announces Proposed Public Offering Of Common Stock 2/25/2015
AMAG Pharmaceuticals, Inc. (AMAG) Announces Proposed Public Offering Of $125 Million Of Common Stock 2/25/2015
Celldex (CLDX) Announces Proposed Public Offering Of Common Stock 2/25/2015
Lion Biotechnologies, Inc. Announces Its Listing On The Nasdaq Global Market 2/25/2015
ESSA Pharma Inc. Announces Confidential Submission Of Draft Registration Statement On Form 20-F With The SEC 2/25/2015
Actavis (ACT) Announces Pricing Of Public Offerings Of Ordinary Shares And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Allergan (AGN) 2/25/2015
Infinity Pharmaceuticals Inc. (INFI) Provides Company Update And Reports Full-Year 2014 Financial Results 2/25/2015
Notice Of Annual General Meeting Of NeuroVive Pharmaceutical AB 2/25/2015
Regen BioPharma Announces Preferred Stock Dividend 2/25/2015
Xencor Announces Proposed Public Offering Of Common Stock 2/24/2015
OXIS International, Inc. (OXIS) Biotech Issues Letter To Shareholders 2/24/2015
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 2/24/2015
Vigilant Biosciences Closes $5.5 Million Series B Round Of Funding 2/24/2015
Alkermes plc (ALKS) Announces Webcast Of Analyst And Investor Event On March 2, 2015 2/24/2015
Merck & Co. (MRK), On Behalf Of Its Wholly Owned Subsidiary Cubist Pharmaceuticals, Inc. (CBST), Announces Results Of Tender Offer For Cubist’s 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes Due 2018 And 1.875% Convertible Senior Notes Due 2020 2/24/2015
GENFIT Corp. (ALGFT): Minutes Of The Combined General Shareholders' Meeting Of February 24, 2015 2/24/2015
Theravance, Inc. (THRX) Announces Cash Dividend Of $0.25 Per Share Payable To Stockholders Of Record As Of March 12, 2015 2/24/2015
XBiotech Plans To Conduct Initial Public Offering Of Its Common Stock 2/24/2015
AmerisourceBergen Corporation (ABC) Completes Tender Offer For Outstanding Shares Of MWI Veterinary Supply 2/24/2015
BioMarin (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2/23/2015
Loxo Oncology (LOXO) Announces Date Of 2015 Program Guidance Webcast And Conference Call 2/23/2015
Vital Therapies, Inc. (VTI) (VTL) To Ring The Nasdaq Stock Market Closing Bell 2/23/2015
Heat Biologics To Host Key Opinion Leader Meeting On February 26 In New York City 2/23/2015
Ariad (ARIA) Touts Impressive Financials But Investors Still Push for CEO Ouster 2/23/2015
CollabRx, Inc. Announces Pricing Of Public Offering Of Approximately $4,800,000 Of Common Stock And Warrants 2/20/2015
FEI Company Announces Date For Investor Conference Participation 2/20/2015
HEALTHSOUTH Declares Dividend On Common Stock And On 6.5% Series A Convertible Perpetual Preferred Stock 2/20/2015
AtheroNova Inc. (AHRO.OB) Receives Additional Notices Of Debt Acceleration 2/20/2015
Neurocrine Biosciences, Inc. (NBIX) Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares 2/20/2015
3SBio Inc. (SSRX) Files for Hong Kong IPO; May Raise Up To $500 Million 2/20/2015
GENFIT Corp. (ALGFT) Announces Its Turnover And Cash Situation As Of December 31, 2014 2/20/2015
Ariad (ARIA) Confirms Receipt Of Sarissa Capital Management’s Nomination Of Director Candidates 2/20/2015
Tekla Life Sciences Investors Declares Stock Distribution 2/20/2015
Innophos Holdings, Inc. Announces Annual Meeting 2/20/2015
Best Hair in Biopharma Race Heats Up As Bristol-Myers Squibb (BMY) Elicker Pulls Ahead 2/20/2015
Actavis (ACT) to Officially Adopt Allergan (AGN) Name 2/20/2015
Fake Quote Scandal: Medical Marijuana Firm CEN Biotech Receives Major Setback 2/20/2015
The Medicines Company (MDCO) Will See Dynamic 2015, As Trials, Approvals Gain: Citi 2/20/2015
Atara Biotherapeutics (ATRA) Announces Closing Of Underwritten Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 2/19/2015
Achillion (ACHN) Announces Closing Of Public Offering Of Common Stock 2/19/2015
Neurocrine Biosciences, Inc. (NBIX) Prices Public Offering Of Common Stock 2/19/2015
CEN Biotech Shareholder Update 2/19/2015
Cleveland Biolabs Inc. (CBLI) Announces Receipt of Letter From NASDAQ Confirming Compliance With Minimum Bid Price Requirement 2/18/2015
Cell MedX Corp. (CMXC) Commences Trading On OTCQB Venture Stage Marketplace 2/18/2015
Neurocrine Biosciences, Inc. (NBIX) Announces Proposed Public Offering Of $225 Million Of Common Stock 2/18/2015
RedHill Biopharma Ltd. (RDHL) Announces Full Exercise Of Underwriters' Over-Allotment Option 2/18/2015
CollabRx, Inc. Regains Compliance On Bid Price 2/18/2015
Inotek Pharmaceuticals Corporation Announces Pricing Of Initial Public Offering Of 6,667,000 Shares Of Common Stock And 5.0% Convertible Senior Notes Due 2020 2/18/2015
Cellectis SA Shareholders General Meeting Of February 16, 2015 2/18/2015
Transition Therapeutics Inc. (TTH.TO) Announces Closing Of Public Offering Of US$23 Million Of Common Shares 2/18/2015
Ultragenyx Pharmaceuticals (RARE) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/17/2015
Novogen Limited (NVGN) To Hold Investor Briefing In New York 2/17/2015
Novogen Limited (NVGN) To Hold Investor Briefing In New York 2/17/2015
VolitionRX Announces Exercise Of Over-Allotment Option In Previously Announced Public Offering 2/17/2015
IMRIS Regains Compliance With NASDAQ Listing Requirements 2/17/2015
Biotech Investor Alex Rabinovich Increases Stake In XTL Biopharmaceuticals Ltd. (XTLB) 2/17/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Releases Letter To Shareholders 2/17/2015
Peak Pharmaceuticals, Inc. Provides Business Update For The First Quarter Of Fiscal 2015 2/17/2015
Teleflex Incorporated (TFX) To Present At The Raymond James 36th Annual Institutional Investors Conference 2/17/2015
Juvenile Diabetes Research Foundation To Ring The Nasdaq Stock Market Closing Bell 2/16/2015
AtheroNova Inc. (AHRO.OB) Receives Notice Of Debt Acceleration 2/16/2015
TRICON: CHI’s Molecular Medicine Tri-Conference Kicks Off Despite Holiday, Slowed Travel 2/16/2015
Bellerophon Therapeutics (BLPH) Announces Pricing Of Its Initial Public Offering 2/13/2015
NeuroBioPharm's Shareholders Approve Arrangement With Neptune Technologies & Bioressources Inc. 2/13/2015
Idera Pharmaceuticals, Inc. (IDRA) Announces Pricing Of Public Offering Of Common Stock 2/13/2015
EyeGate Pharma Prices $4,100,000 Initial Public Offering 2/13/2015
Telesta Therapeutics Publishes Its 6 Month Financial Results To December 31, 2014 And Provides Important Corporate Updates 2/13/2015
RedHill Biopharma Ltd. (RDHL) Announces Closing Of Public Offering Of Its American Depository Shares 2/13/2015
Threshold Pharmaceuticals, Inc. (THLD) Announces Pricing Of $30 Million Offering Of Common Stock And Warrants 2/13/2015
VolitionRX Announces Closing Of Public Offering Of Common Stock 2/12/2015
Transition Therapeutics Inc. (TTH.TO) Announces Pricing Of Public Offering Of US$20 Million Of Common Shares 2/12/2015
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Pricing Of A Public Offering Of Common Stock And Warrants 2/12/2015
Achillion (ACHN) Announces Pricing Of Public Offering Of Common Stock 2/12/2015
ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Exercise Of Option To Purchase Additional Shares 2/12/2015
Atara Biotherapeutics (ATRA) Announces Pricing Of Its $65.5 Million Offering Of Common Stock 2/12/2015
DelMar Pharmaceuticals Announces December 31, 2014 Financial Results And Provides Corporate Update 2/12/2015
Immunomedics, Inc. (IMMU) Announces Completion Of Offering Of $85 Million Of 4.75% Convertible Senior Notes Due 2020 2/12/2015
Venaxis, Inc. (APPY) Business Update 2/12/2015
Incyte Corporation (INCY) Reports 2014 Fourth-Quarter And Year-End Financial Results; Provides 2015 Financial Guidance; Updates Shareholders On Key Clinical Programs 2/12/2015
Harvard Apparatus Regenerative Technology Announces Pricing Of Public Offering Of Common Stock And Series B Convertible Preferred Stock 2/12/2015
PhytoTech Medical Limited (ASX:PYL) Letter To Shareholders 2/12/2015
Invitation - Presentation Of Swedish Orphan Biovitrum's Fourth Quarter And Full Year Results 2014 2/12/2015
Invitae Announces Pricing Of Initial Public Offering Of Common Stock 2/12/2015
Ocata Therapeutics Withdraws Offering Of Common Stock 2/12/2015
Cleveland Biolabs Inc. (CBLI) Announces Annual Meeting 2/12/2015
Intercept Pharmaceuticals (ICPT) Announces Completion Of Public Offering And Exercise Of Option To Purchase Additional Shares 2/11/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 2/11/2015
Apricus Biosciences (APRI) Announces $11 Million Registered Direct Offering With Sarissa Capital Management Lp 2/11/2015
Anthera Pharmaceuticals, Inc. (ANTH) Regains Compliance With Nasdaq Listing Requirements 2/11/2015
Asterias Biotherapeutics Completes Public Offering And Private Placement Of Common Stock 2/11/2015
TrovaGene, Inc. Announces Closing Of Public Offering Of Common Stock 2/11/2015
TherapeuticsMD, Inc.  (TXMD) Announces Offering Of Common Stock 2/11/2015
TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Common Stock Offering 2/11/2015
Velos, Inc. Revenue Up 43% 2/11/2015
Ohr Pharmaceutical (OHRP) Announces Closing Of Public Offering Of Common Stock 2/11/2015
Transition Therapeutics Inc. (TTH.TO) Announces Public Offering Of Common Shares 2/11/2015
AmorChem Invests In A Mucoadhesive Nanoparticle Drug Delivery Platform 2/11/2015
BIOCEO15: Kite Pharma (KITE) Debuts Near-Term Plans, Says It’s Tackling "Toxicity Issues" 2/10/2015
BIOCEO15: New Report On Biotech Venture Capital Over Last 10 Years Finds Heavy Focus on R&D 2/10/2015
BIOCEO15: Sarepta (SRPT) CEO Feels Backlash After Saying Ebola Research Isn’t in "Shareholder Interest" 2/10/2015
Pfizer (PFE) Commences $5 Billion Accelerated Share Repurchase 2/10/2015
RedHill Biopharma Ltd. (RDHL) Prices Public Offering Of Its American Depository Shares 2/10/2015
RedHill Biopharma Ltd. (RDHL) Announces Proposed Public Offering Of Its American Depository Shares 2/10/2015
Atara Biotherapeutics (ATRA) Announces Proposed Offering Of Common Stock 2/10/2015
Idera Pharmaceuticals, Inc. (IDRA) Announces Proposed Public Offering Of Common Stock 2/10/2015
Paratek Pharmaceuticals, Inc. Adopts Inducement Equity Incentive Plan Under NASDAQ Listing Rule 5635(c)(4) 2/10/2015
Suven Life Sciences Ltd Revenue Growth At 9% While PAT Is Down By 11.55% For The 3rd Quarter Ended Dec 2014 2/10/2015
DelMar Pharmaceuticals Completes Offer To Exchange Common Stock For Outstanding Warrants 2/10/2015
ProSensa Holding N.V. (RNA) Announces Voluntary Delisting And Advance Liquidation Distribution 2/10/2015
Pfizer (PFE) Commences $5 Billion Accelerated Share Repurchase 2/10/2015
BIND Therapeutics (BIND) Announces Closing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 2/10/2015
Teva Pharmaceutical Industries (TEVA) Files 2014 Annual Report On Form 20-F 2/10/2015
BIOCEO15: Financial Panel Sees Deal-Making Up in 2015, Names CAR-T, Plaque Attackers as Hot Targets 2/9/2015
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2/9/2015
BNP Paribas Notify Of 5.08% Shareholding In Galapagos NV (GLPG.BR) 2/9/2015
BIO Releases First-Of-Its-Kind Study On Venture Funding For Therapeutic Innovation 2/9/2015
Navidea Biopharmaceuticals (NAVB) Reports Preliminary 2014 Revenue; Provides Update On New Commercial Strategy 2/9/2015
Sartorius Closes Sale of Industrial Technologies Division 2/9/2015
Regulus Therapeutics, Inc. (RGLS) To Ring The Nasdaq Stock Market Closing Bell 2/9/2015
Catalyst Pharmaceuticals (CPRX) Announces Closing Of Previously Announced Public Offering 2/9/2015
TONIX Pharmaceuticals, Inc. (TNXP) Announces Closing Of $28.7 Million Public Offering Of Common Stock 2/9/2015
VolitionRX Prices Public Offering of Common Stock 2/6/2015
Oncothyreon Inc. (ONTY) Prices $22 Million Concurrent Public Offerings Of Common Stock And Preferred Stock 2/6/2015
TrovaGene, Inc. Announces Pricing Of Public Offering Of Common Stock 2/6/2015
Ohr Pharmaceutical (OHRP) Announces Proposed Public Offering Of Common Stock 2/6/2015
Immunomedics, Inc. (IMMU) Announces Pricing Of Offering of $85 Million Of 4.75% Convertible Senior Notes Due 2020 2/6/2015
Proteon Therapeutics, Inc. (PRTO) To Ring The Nasdaq Stock Market Opening Bell On February 9th 2/6/2015
Columbia Laboratories, Inc. (CBRX) Announces Date Of 2015 Annual Meeting Of Stockholders 2/6/2015
Ohr Pharmaceutical (OHRP) Prices $25,000,000 Public Offering Of Common Stock 2/6/2015
Oncothyreon Inc. (ONTY) Announces Proposed Public Offerings 2/6/2015
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 2/6/2015
NuGene International Commences Trading Under Ticker NUGN 2/6/2015
22nd Century Group, Inc. Files 2014 Annual Report And Announces Conference Call To Provide Business Update 2/6/2015
Asterias Biotherapeutics Announces Public Offering Of Common Stock 2/5/2015
Immunomedics, Inc. (IMMU) Announces Proposed Offering of $85 Million of Convertible Senior Notes Due 2020 2/5/2015
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 2/5/2015
Asterias Biotherapeutics Prices Public Offering Of Common Stock 2/5/2015
AxoGen, Inc. (AXGN) Announces Proposed Public Offering Of Common Stock 2/5/2015
Peak Pharmaceuticals, Inc. Updates Ticker To PKPH Completing Its Recent Brand Repositioning 2/5/2015
BIND Therapeutics (BIND) Prices Public Offering Of Common Stock And Warrants To Purchase Common Stock 2/5/2015
Ultragenyx Pharmaceuticals (RARE) Announces Pricing Of Public Offering Of Common Stock 2/5/2015
Intercept Pharmaceuticals (ICPT) Announces Pricing Of Public Offering 2/5/2015
Express Scripts Inc. Cheers As Data Shows Drug Pricing Up 3-Fold, Even When Adjusted For Inflation, Survival 2/5/2015
Pfizer (PFE) Invites Investors, Analysts And Media To Join Conference Calls Discussing Pfizer’s Proposed Acquisition Of Hospira, Inc. 2/5/2015
Tekmira (TKMR) Announces Filing Of Definitive Proxy Statement And Voluntary Delisting From The TSX 2/5/2015
Macrocure (MCUR) Announces Special General Meeting Of Shareholders For Approval Of Amendments To Compensation Package Of CEO And 2013 Share Incentive Plan 2/5/2015
Oxford Immunotec Global PLC Announces Closing Of Underwritten Offering Of Ordinary Shares And Underwriters’ Exercise Of Option To Purchase Additional Shares 2/4/2015
Mirati Therapeutics  (MRTX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/4/2015
Omeros Corporation (OMER) Closes $84 Million Public Offering of Common Stock And Pre-Funded Warrants 2/4/2015
TONIX Pharmaceuticals, Inc. (TNXP) Announces Proposed Public Offering Of Common Stock 2/4/2015
Intercept Pharmaceuticals (ICPT) Announces Proposed Public Offering Of Common Stock 2/4/2015
Ultragenyx Pharmaceuticals (RARE) Announces Proposed Public Offering Of Common Stock 2/4/2015
ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Pricing Of Public Offering Of Common Stock 2/4/2015
Catalyst Pharmaceuticals (CPRX) Announces Commencement Of Public Offering Of Common Stock 2/4/2015
Catalyst Pharmaceuticals (CPRX) Prices Public Offering Of Common Stock 2/4/2015
Capricor Therapeutics, Inc. Announces $7 Million Private Placement Of Common Stock 2/4/2015
Unilife Corporation (UNIS) Announces Closing Of Underwritten Offering Of Common Stock And Full Exercise Of The Underwriters' Option To Purchase Additional Shares 2/4/2015
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 2/4/2015
TONIX Pharmaceuticals, Inc. (TNXP) Prices Underwritten Public Offering Of Common Stock 2/4/2015
KYTHERA Biopharmaceuticals, Inc. (KYTH) Grants Stock Options Under Inducement Program 2/4/2015
Cellular Biomedicine Group (CBMG) "Stock News Now" Video Interview Now Available Online 2/4/2015
Gilead Sciences, Inc. (GILD) Announces 43 Cents Quarterly Dividend Program And $15 Billion Share Buyback Program 2/4/2015
Retrophin (RTRX) Announces Voting Results Of Special Meeting Of Stockholders 2/4/2015
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At Two Upcoming Conferences 2/4/2015
Retrophin (RTRX) Announces Voting Results Of Special Meeting Of Stockholders 2/4/2015



//-->